The Story of O3: The Ozone Documentary with Luciano Blotta

In today's episode, we're unraveling a story that challenges the very foundation of modern medicine. Over a century ago, a pivotal report forever changed how we approach health, sidelining natural therapies in favor of profit-driven pharmaceuticals. What if one of those suppressed therapies could unlock remarkable healing potential that could reverse many of the chronic conditions so many suffer from? Our guest is an Emmy-nominated filmmaker who joins us to explore the often-forgotten miracle molecule that delivers profound health benefits.

This is the Story of O3: The Ozone Documentary with Luciano Blotta.

EPISODE VIDEO HIGHLIGHTS
▪ Watch the Entire Episode
▪ Ozone (O3): The Miracle Molecule You’ve Never Heard Of
▪ The Flexner Report: Rockefeller’s Impact on Natural Medicine
▪ The Powerful Healing Benefits of Ozone Therapy
▪ The Ozone Miracle: A New Film About Health and Healing
▪ Why More People Should Do Chelation Therapy
▪ Big Pharma’s Profit Motive: Are We Getting the Best Treatment?
▪ The Truth About Ozone Therapy and Healing

CONNECT WITH LUCIANO BLOTTA
▪ Website - O3 Movie
▪ Donate to the O3 Movie Kickstarter
▪ Instagram - O3 Movie
▪ Instagram - Luciano Blotta
▪ LinkedIn

LEARN MORE ABOUT US
▪ Visit our website to learn more about Innovative Medicine
▪ Take our assessment and set up a free 20-minute consult to learn more about becoming a patient, or feel free to contact us
▪ Follow Innovative Medicine on Instagram
▪ Subscribe, watch, give us a like on YouTube
▪ ‘Your Health. Your Story.’ Podcast: Follow, listen, leave us a review on Spotify or Apple Podcasts
▪ Follow our podcast host, Caspar Szulc on Instagram
▪ Sign up for Caspar’s newsletter

LEARN MORE ABOUT NADOVIM
Doctor-formulated, clinically-tested NAD+ supplement. Visit our website and save 10% on your first order by using code NADOVIM10.

Disclaimer: The content presented on the podcast is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.